MedTrace Logo

Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease

NCT00001295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2145

Last updated 2019-12-17

No results posted yet for this study

Summary

This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Caryn Steakley, R.N. · National Cancer Institute (NCI)

Eligibility

Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1992-01-29
Completion
2016-08-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00001295 on ClinicalTrials.gov